Patent · US Active

Modulatable switch for selection of donor modified cells

US10426798B2 · kind B2 · utility

1Cited by

2References

17Claims

0Family size

Assignees

Calimmune, Inc. · US
Calimmune Australia PTY LTD · AU

Inventors

Christopher Walter ALMA · Parramatta, AU
Jeffrey S. Bartlett · Columbus, US
Louis Randall Breton · Tucson, US
Geoffrey Phillip Symonds · Mandurah, AU
Ming Yan · Los Angeles, US

Key dates

Filing date	Jul 18, 2018
Grant date	Oct 1, 2019
Priority date	—
Expiry date	Jul 18, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2239/48
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The disclosed methods are generally directed to preventing, treating, suppressing, controlling or otherwise mitigating side effects of T-cell therapy, the T-cell therapy designed to accelerate immune reconstitution, induce a GVM effect, and/or target tumor cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.